INSIGHTS ON LIQUID DOSE MANUFACTURING

• Low Temperature Storage Containment For Vial And Syringe Systems

  With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.

• Enable Low Volume Delivery Of Proteins In Aqueous Solutions

  Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

• Sterility Testing Of Products To Be Diluted In Isopropyl Myristate

  Discover one possible test set-up to dilute a product in isopropyl myristate, filter it, and rinse the membrane to eliminate residues that may inhibit microbial growth.

• Finding The Right Aseptic Processing Approach

  How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

• CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever

  12/29/2025

  As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

• Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

  9/8/2025

  This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.

• Raise Your Standards With Downflow Booth Airflow Containment

  1/30/2026

  Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.

• Upperton Capabilities Update April 2026: Fill/Finish

  4/28/2026

  An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.

• EU GMP-Annex 1: Changes, Challenges, And Ready-To-Use Sterile Packaging

  8/27/2024

  Leveraging a pre-sterilized containment solution that meets the requirements of Annex 1 and outsources non-core activities can help prevent contamination and reduce the effort and liability of the CCS.